Volume 1, issue 1, December 2016
15 articles in this issue
-
-
-
-
Longitudinal change in Paced Auditory Serial Addition Test (PASAT) performance following immunoablative therapy and haematopoietic stem cell transplant in multiple sclerosis
Authors (first, second and last of 7)
-
Rituximab suppresses disease activity after natalizumab withdrawal: an exploratory study
Authors (first, second and last of 6)
-
Hands on Alemtuzumab-experience from clinical practice: whom and how to treat
Authors (first, second and last of 4)
-
-
Stroop event-related potentials as a bioelectrical correlate of frontal lobe dysfunction in multiple sclerosis
Authors (first, second and last of 10)
-
Increased expression of dedicator-cytokinesis-10, caspase-2 and Synaptotagmin-like 2 is associated with clinical disease activity in multiple sclerosis
Authors (first, second and last of 12)
-
The heritage of glatiramer acetate and its use in multiple sclerosis
Authors (first, second and last of 18)
-
-
A real world experience with fingolimod in active RRMS patients naïve to second-line agents: a 2 years, intention-to-treat, observational, single center study
Authors (first, second and last of 8)
-
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life
Authors (first, second and last of 8)
-
-
